Medicamen Biotech reports net loss of Rs 1.27 crore in the March 2013 quarter

Net loss of Medicamen Biotech reported to Rs 1.27 crore in the quarter ended March 2013 as against net profit of Rs 2.44 crore during the previous quarter ended March 2012. Sales declined 41.61% to Rs 18.54 crore in the quarter ended March 2013 as against Rs 31.75 crore during the previous quarter ended March 2012.

For the Audited full year,net loss reported to Rs 4.93 crore in the year ended March 2013 as against net loss of Rs 0.82 crore during the previous year ended March 2012. Sales declined 36.34% to Rs 64.00 crore in the year ended March 2013 as against Rs 100.53 crore during the previous year ended March 2012.

ParticularsQuarter EndedYear EndedMar. 2013Mar. 2012% Var.Mar. 2013Mar. 2012% Var.Sales18.5431.75 -42 64.00100.53 -36 OPM %-2.7510.93 -125 -2.222.03 -209 PBDT-0.912.86 PL -3.300.86 PL PBT-1.302.49 PL -4.88-0.64 -663 NP-1.272.44 PL -4.93-0.82 -501

Powered by Capital Market - Live News